---

Cost analysis study of antihypertensive agents available in India

---

Original Article

Author Details : Rani Kumari Beck*, Ratan Kumar, Vibhakar Kumar, Shweta Kachhap

Volume : 7, Issue : 3, Year : 2020

Article Page : 181-188

https://doi.org/10.18231/j.ijpp.2020.031

Suggest article by email

Get Permission

---

Abstract

Aim: Hypertension is a global public health problem. To decrease its morbidity and mortality it needs
lifelong treatment. There is a wide range of variation in the prices of antihypertensive drugs marketed in
India. Thus, a study was planned to evaluate the difference in cost of different brands of same active drug
by calculating percentage variation of cost.
Materials and Methods: The cost of different brands of commonly used antihypertensive drugs was sorted
out by referring latest CIMS, MIMS and Drug Today. The cost of 10 dosage forms (Tablets/Capsules) in
INR of each brand, cost Ratio and percentage Cost Variation were calculated.
Results: The percentage variation in the cost was above 100% with most of single drug therapy
for hypertension and is 42 out of 69. It’s found maximum in Atenolol (12.5mg) 880%, Amlodipine
(5mg) 460%, Nifidipine (30mg) 456.29% and Diltiazem (90mg) 407.02%. Among the combination
therapy percentage variation in the cost was above 100% in 16 out of 26. It’s found maximum in
Lisinopril+Hydrochlorothiazide (5mg+12.5mg) 926%, Telmisartan+Hydrochlorothiazide (40mg+12.5mg)
254.75%, Amlodipine+Losartan (5mg+50mg) 246.96% and Amlodipine+Enalapril (5mg+5mg) 217.20%.
Conclusion: The average percentage price variation of the same molecules of antihypertensive drugs
manufactured by different pharmaceuticals company in India is very wide. So, government, pharmaceutical
company, marketing manager and prescribing doctors should think about variation of cost and do needful
for providing maximum benefits to the patients receiving antihypertensive drugs.

Keywords: Cost analysis, Antihypertensive drugs, Price variation, Brands.

How to cite : Beck R K , Kumar R , Kumar V , Kachhap S, Cost analysis study of antihypertensive agents available in India. Indian J Pharm Pharmacol 2020;7(3):181-188

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.